EQS-Adhoc

2020 Preliminary unaudited top-line figures - Seite 2

During the year our Marketing and Medical Education Programs never stopped, thanks to the implementation of several tactical changes and new online based initiatives which proved to be effective in maintaining existing customers and reaching new ones. Also, innovation continued and over 30 new products across our business lines were registered with more expected in the first half of this year. Growth investments carried on with significant salesforce expansion across all geographies and investment in additional surgical instruments to serve new customers.

Revenues recorded in 2020 had significant differences among product lines and geographies due to different levels of Covid-19 related restrictions during the year and diverse patterns of momentum in pre-Covid sales growth.

Medacta registered a negative growth in the core business (Hip -6.1% and Knee -4.1%) because of the already mentioned restrictions and postponement of elective procedures in the first half, partially compensated by an effective backlog recovery. The last few months of the year did see a pandemic resurgence mainly in Europe and North America.

The Extremities product line had a very positive performance (+46.6%), growing in all geographies despite the Covid-19 impact, thanks to the strong momentum carried over by new business and expansion of product range, with an increase of our market share, especially in Europe.

The Spine business line recorded good performance (+14.6%) driven by newly launched products, salesforce expansion and a gain in market share, particularly in the US.

Below we report the 2020 sales break-down by product line:

(Million Euro)	31.12.2020	31.12.2019	Reported Growth	Constant Currency Growth
Hip	153.1	163.9	-6.6%	-6.1%
Knee	106.2	111.7	-4.9%	-4.1%
Extremities*	14.3	9.7	46.5%	46.6%
Spine	28.9	25.3	14.4%	14.6%
TOTAL	302.5	310.6	-2.6%	-2.1%
* Extremities include Shoulder and Sports Med revenues

 

In terms of geographic trend, Europe registered a negative growth (-6.0%) with a significant recovery in the second half of the year. The most affected markets were France, Italy and Belgium, while the "DACH" area recorded the smallest impact with Germany growing over the prior year.